Document Detail


Der Placebo-Effekt in biosemiotischer Sicht.
MedLine Citation:
PMID:  9892826     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Placebo from a Biosemiotic Point of View The rise and success of modern science, first in physics, later in medicine, was based on a mechanic linear model of causality. Its only category of explanation of natural processes is the mechanical machine. As human beings using and processing signs we cannot recognize ourselves in this reductionistic model. As all living creatures we perceive, interpret and answer the stimuli of the environment. To explain the behaviour of organisms we need a semiotic-circular causality. Semiotics, the study of signs, can be subdivided in semantics, the theory of meaning of signs, in syntax, the theory of the forms and the arrangement of signs, and in pragmatics, the theory of the contextual rules of communication. Semiotics is not exclusively concerned with language, but helps as so-called biosemiotics also to explain the network of communication of a living organism. The 'Denkstil' of established pharmacology is likewise restricted to mechanistic causality. One of the consequences is the fact that theplacebo effect is defined as 'non-specific' or 'non-characteristic'. Such negative definitions exclude concrete questions of investigation. We have to accept a biosemiotic view in pharmacology, to see drugs as signs consisting of a physical vehicle equipped with meaning. The therapy with drugs must be seen in a broader treatment context investigated by pharmacopragmatics. The semiotic expansion of pharmacology does not invalidate the achievements of classic pharmacology, but elucidates in addition a view of the pragmatic components and makes the scientific integration of the placebophenomenon into drug therapy possible. The placebo effect loses its inconsistency.
Authors:
Schönbächler
Related Documents :
7555446 - Fk-506 and cyclosporine a (csa) immunomodulation of the human gut mucosal immune system.
1250236 - Immunosuppressive treatment of behcet's disease.
20618466 - Progressive multifocal leukoencephalopathy and antipsoriatic drugs: assessing the risk ...
11908926 - Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and c...
20799366 - Intranasal clobazam delivery in the treatment of status epilepticus.
23438726 - Non-antidepressant pharmacological treatment of obsessive compulsive disorder: a compre...
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Forschende Komplementarmedizin     Volume:  5 Suppl S1     ISSN:  1021-7096     ISO Abbreviation:  Forsch Komplementarmed     Publication Date:  1998  
Date Detail:
Created Date:  1999-01-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9440428     Medline TA:  Forsch Komplementarmed     Country:  -    
Other Details:
Languages:  ENG     Pagination:  18-22     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Das Resonanzph??nomen.
Next Document:  The Many Meanings of Placebo.